CNC:NYE-Centene Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 57.46

Change

0.00 (0.00)%

Market Cap

USD 30.37B

Volume

8.03M

Analyst Target

USD 85.36
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 566.72B
ELV Elevance Health Inc

N/A

USD 95.26B
MOH Molina Healthcare Inc

N/A

USD 18.86B
OSCR Oscar Health Inc

N/A

USD 4.12B
NEUE NeueHealth Inc

N/A

USD 0.05B
CI Cigna Corp

N/A

N/A
CVS CVS Health Corp

N/A

N/A
HUM Humana Inc

N/A

N/A

ETFs Containing CNC

MVPA Advisor Managed Portfolio.. 4.86 % 0.00 %

N/A

USD 0.06B
AVDR 2.70 % 0.00 %

N/A

N/A
DXSD:F 2.30 % 0.00 %

N/A

N/A
DXSD:XETRA 2.30 % 0.00 %

N/A

N/A
FSYD Fidelity Sustainable High.. 0.04 % 0.00 %

N/A

USD 0.03B
FSBD Fidelity Sustainable Core.. 0.01 % 0.00 %

N/A

USD 0.01B
FHH:CA First Trust AlphaDEX US H.. 0.00 % 0.77 %

N/A

CAD 0.01B
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

N/A

N/A
JNKS:LSE SSgA SPDR ETFs Europe I p.. 0.00 % 0.00 %

N/A

USD 0.19B
SYBK:F SSgA SPDR ETFs Europe I p.. 0.00 % 0.00 %

N/A

USD 0.14B
SYBK:XETRA SPDR Barclays 0-5 Year US.. 0.00 % 0.00 %

N/A

USD 0.13B
GBLO 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

CAD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -22.57% 38% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.57% 38% F 9% A-
Trailing 12 Months  
Capital Gain -20.86% 38% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -20.86% 25% F 8% B-
Trailing 5 Years  
Capital Gain -3.25% 50% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.25% 50% F 22% F
Average Annual (5 Year Horizon)  
Capital Gain 2.51% 50% F 43% F
Dividend Return 2.51% 25% F 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 25.85% 38% F 42% F
Risk Adjusted Return 9.71% 25% F 28% F
Market Capitalization 30.37B 67% D+ 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.